Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade
NCT ID: NCT04510337
Last Updated: 2021-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-04-02
2021-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade
NCT04013243
Magnesium Versus High Dose Fentanyl in Endotracheal Intubation
NCT04544163
Effect of Pre-treatment With Magnesium Sulfate on the Duration of Deep Neuromuscular Blockade With Rocuronium
NCT02989272
Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia
NCT05442931
Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block
NCT02888067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard rocuronium
patients received rocuronium 0.6mg/kg
standard rocuronium dose
0.6 mg/kg rocuronium during induction of anesthesia
Magnesium
patients received 100 ml saline with 50mg/kg magnesium sulphate infusion over 10 minutes
Magnesium sulfate
50 mg/kg magnesium sulphate added to 0.40 mg/kg rocuronium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard rocuronium dose
0.6 mg/kg rocuronium during induction of anesthesia
Magnesium sulfate
50 mg/kg magnesium sulphate added to 0.40 mg/kg rocuronium
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ASA I-II
Age 30-70 years
Exclusion Criteria
Neuromuscular disease
Large glottic and/or supra-glottic lesions with or without breathing difficulties
Known allergy to any of the used drug
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Lecturer of anesthesia and pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Mohamed A Wadod, MD
Role: STUDY_DIRECTOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201617031.2P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.